secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fresh Tracks Therapeutics, Inc. (—)
CIK:        0000819050
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0000819050-23-000040
Event type: regulatory
Sentiment:  negative
Materiality: 0.72
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Fresh Tracks Therapeutics receives Nasdaq bid-price non-compliance notice; board member resigns
--------------------------------------------------------------------------------

- Nasdaq notified Fresh Tracks on Apr 24, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Oct 23, 2023) to regain compliance; possible 180-day extension if eligible.
- Director Gary A. Lyons will resign at 2023 annual meeting due to overboarding concerns; no disagreement with company.
- Company monitoring bid price and considering options, but no assurance of regaining compliance or avoiding delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/819050/000081905023000040/0000819050-23-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/819050/000081905023000040/frtx-20230421.htm
  HTML page:      https://secwatch.observer/filing/0000819050-23-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer